These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of tricuspid valve regurgitation following laser lead extraction†. Pecha S; Castro L; Gosau N; Linder M; Vogler J; Willems S; Reichenspurner H; Hakmi S Eur J Cardiothorac Surg; 2017 Jun; 51(6):1108-1111. PubMed ID: 28204134 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of tricuspid regurgitation and pericardial effusions following pacemaker and defibrillator lead extraction. Glover BM; Watkins S; Mariani JA; Yap S; Asta J; Cusimano RJ; Ralph-Edwards AC; Cameron DA Int J Cardiol; 2010 Dec; 145(3):593-4. PubMed ID: 20598762 [No Abstract] [Full Text] [Related]
4. Transvenous pacemaker lead removal is safe and effective even in large vegetations: an analysis of 53 cases of pacemaker lead endocarditis. Ruttmann E; Hangler HB; Kilo J; Höfer D; Müller LC; Hintringer F; Müller S; Laufer G; Antretter H Pacing Clin Electrophysiol; 2006 Mar; 29(3):231-6. PubMed ID: 16606389 [TBL] [Abstract][Full Text] [Related]
5. Laser lead extraction: predictors of success and complications. Roux JF; Pagé P; Dubuc M; Thibault B; Guerra PG; Macle L; Roy D; Talajic M; Khairy P Pacing Clin Electrophysiol; 2007 Feb; 30(2):214-20. PubMed ID: 17338718 [TBL] [Abstract][Full Text] [Related]
6. Laser lead extraction in adult congenital heart disease. Khairy P; Roux JF; Dubuc M; Thibault B; Guerra PG; Macle L; Mercier LA; Dore A; Roy D; Talajic M; Pagé P J Cardiovasc Electrophysiol; 2007 May; 18(5):507-11. PubMed ID: 17343721 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation. Nazmul MN; Cha YM; Lin G; Asirvatham SJ; Powell BD Europace; 2013 Mar; 15(3):409-13. PubMed ID: 23193162 [TBL] [Abstract][Full Text] [Related]
8. Laser-assisted lead extraction: the European experience. Kennergren C; Bucknall CA; Butter C; Charles R; Fuhrer J; Grosfeld M; Tavernier R; Morgado TB; Mortensen P; Paul V; Richter P; Schwartz T; Wellens F; Europace; 2007 Aug; 9(8):651-6. PubMed ID: 17597078 [TBL] [Abstract][Full Text] [Related]
9. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. Lin G; Nishimura RA; Connolly HM; Dearani JA; Sundt TM; Hayes DL J Am Coll Cardiol; 2005 May; 45(10):1672-5. PubMed ID: 15893186 [TBL] [Abstract][Full Text] [Related]
10. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. Kim JB; Spevack DM; Tunick PA; Bullinga JR; Kronzon I; Chinitz LA; Reynolds HR J Am Soc Echocardiogr; 2008 Mar; 21(3):284-7. PubMed ID: 17604958 [TBL] [Abstract][Full Text] [Related]
11. Lead dependent tricuspid dysfunction: Analysis of the mechanism and management in patients referred for transvenous lead extraction. Polewczyk A; Kutarski A; Tomaszewski A; Brzozowski W; Czajkowski M; Polewczyk M; Janion M Cardiol J; 2013; 20(4):402-10. PubMed ID: 23913459 [TBL] [Abstract][Full Text] [Related]
12. Lead vegetations in patients with local and systemic cardiac device infections: prevalence, risk factors, and therapeutic effects. Golzio PG; Fanelli AL; Vinci M; Pelissero E; Morello M; Grosso Marra W; Gaita F Europace; 2013 Jan; 15(1):89-100. PubMed ID: 22968846 [TBL] [Abstract][Full Text] [Related]
13. Tricuspid Regurgitation following Lead Extraction: Risk Factors and Clinical Course. Givon A; Vedernikova N; Luria D; Vatury O; Kuperstein R; Feinberg MS; Eldar M; Glikson M; Nof E Isr Med Assoc J; 2016 Jan; 18(1):18-22. PubMed ID: 26964274 [TBL] [Abstract][Full Text] [Related]
15. The impact of transvenous lead extraction on tricuspid valve function. Coffey JO; Sager SJ; Gangireddy S; Levine A; Viles-Gonzalez JF; Fischer A Pacing Clin Electrophysiol; 2014 Jan; 37(1):19-24. PubMed ID: 23991637 [TBL] [Abstract][Full Text] [Related]
16. Utility and safety of temporary pacing using active fixation leads and externalized re-usable permanent pacemakers after lead extraction. Kawata H; Pretorius V; Phan H; Mulpuru S; Gadiyaram V; Patel J; Steltzner D; Krummen D; Feld G; Birgersdotter-Green U Europace; 2013 Sep; 15(9):1287-91. PubMed ID: 23482613 [TBL] [Abstract][Full Text] [Related]
17. Biventricular defibrillator patients have higher complication rates after revision of recalled leads. Brumberg GE; Kaseer B; Shah H; Saba S; Jain S Pacing Clin Electrophysiol; 2012 Jun; 35(6):665-71. PubMed ID: 22519559 [TBL] [Abstract][Full Text] [Related]
18. Tricuspid regurgitation and implantable devices. Al-Bawardy R; Krishnaswamy A; Rajeswaran J; Bhargava M; Wazni O; Wilkoff B; Tuzcu EM; Martin D; Thomas J; Blackstone E; Kapadia S Pacing Clin Electrophysiol; 2015 Feb; 38(2):259-66. PubMed ID: 25377489 [TBL] [Abstract][Full Text] [Related]
19. Lead-Dependent Infective Endocarditis: The Role of Factors Predisposing to Its Development in an Analysis of 414 Clinical Cases. Polewczyk A; Jacheć W; Janion M; Podlaski R; Kutarski A Pacing Clin Electrophysiol; 2015 Jul; 38(7):846-56. PubMed ID: 25683205 [TBL] [Abstract][Full Text] [Related]
20. Laser-assisted extraction of pacemaker and defibrillator leads: the role of the cardiac surgeon. Gaca JG; Lima B; Milano CA; Lin SS; Davis RD; Lowe JE; Smith PK Ann Thorac Surg; 2009 May; 87(5):1446-50; discussion 1450-1. PubMed ID: 19379883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]